
Penance India Lifescience Private Limited
About Penance India Lifescience Private Limited
Data last updated:
Penance India Lifescience Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC291678. Its GSTIN is 27AAJCP0109K1ZF (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Satyam Kumar Pandey and Sandeepkumar Satyanarayan Upadhyay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Cement Chawl J P Road Near Canara Bank Compund Andheri West, Mumbai, Maharashtra, India – 400058.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.68 Lakh, a decline of 45% compared to the previous year. For the same year it recorded a net loss of ₹4,601 (net margin -0.7%) and EBITDA of ₹11,999 (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 19% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Penance India Lifescience Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressCement Chawl J P Road Near Canara Bank Compund Andheri West, Mumbai, Maharashtra, India – 400058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Penance India Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Penance India Lifescience is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Penance India Lifescience Private Limited, buy the company report.
Financials of Penance India Lifescience Private Limited
FY 2025 filings availablePenance India Lifescience Private Limited reported revenue of ₹6.68 Lakh (down 45% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 45% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 19%. EBITDA rose 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11,999 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4,601 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | -0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Penance India Lifescience Private Limited, buy the company report.
Board of directors of Penance India Lifescience Private Limited
Penance India Lifescience has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyam Kumar Pandey Also directs: Penance India Biotech Private Limited | Director | 27 Feb 2017 | 9 Years 8 Months | Current |
| Sandeepkumar Satyanarayan Upadhyay Also directs: Penance India Biotech Private Limited | Director | 30 Sep 2019 | 7 Years 1 Months | Current |
| Sneha Suresh Varma | Director | 30 Sep 2019 | 7 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Penance India Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Penance India Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Penance India Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCP0109K1ZF | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Penance India Lifescience Private Limited, buy the company report.
Recent activity
Penance India Lifescience Private Limited has 6 board changes on record since 2017: 3 appointments and 3 cessations. The latest: Anilkumar Indramani Pal ceased to be Director on 02 Feb 2022.
Frequently asked questions
Penance India Lifescience is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 February 2017 (9+ years old) and is registered under CIN U74999MH2017PTC291678.
Penance India Lifescience has 3 current directors:
- Satyam Kumar Pandey - Director
- Sandeepkumar Satyanarayan Upadhyay - Director
- Sneha Suresh Varma - Director
The latest financial statements of Penance India Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Penance India Lifescience is 27AAJCP0109K1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Penance India Lifescience is U74999MH2017PTC291678. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Penance India Lifescience was incorporated on 27 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Anilkumar Indramani Pal ceased to be Director on 02 Feb 2022. Ashutosh Mishra ceased to be Director on 25 Oct 2019. Sandeepkumar Satyanarayan Upadhyay was appointed as Director on 30 Sep 2019. Penance India Lifescience has 6 board changes on record in total.
The registered office of Penance India Lifescience is at Cement Chawl J P Road Near Canara Bank Compund Andheri West, Mumbai, Maharashtra, India – 400058.
Penance India Lifescience operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Penance India Lifescience is compliant as of 06 July 2026. The company is actively filing with the Registrar of Companies.

